Trelegy Ellipta 62.5 ug/1

Active Ingredient:
Form:
Brand:
Origin:

Trelegy Ellipta 62.5 ug/1 is a combination inhaler containing fluticasone furoate, umeclidinium bromide, and vilanterol trifenatate. It is designed for respiratory conditions, offering a convenient once-daily treatment option. This inhaler is manufactured by GlaxoSmithKline LLC and is available in a 30-dose pack.

Strength

62.5 ug/1

Pack Size

1 TRAY in 1 CARTON (0173-0893-10) / 1 INHALER in 1 TRAY / 30 POWDER in 1 INHALER

Storage

Not specified

Manufacturer

GlaxoSmithKline LLC

Buy Trelegy Ellipta 62.5 ug/1

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below with your details, and a member of our team will get back to you shortly with pricing and further information.

Uses / Indications

  • Trelegy Ellipta 62.5 ug/1 is primarily used for the maintenance treatment of chronic obstructive pulmonary disease (COPD) and asthma. The combination of fluticasone furoate, umeclidinium bromide, and vilanterol trifenatate works to reduce inflammation, relax airway muscles, and improve breathing. This inhaler is often prescribed for individuals who require a combination of these active ingredients to manage their respiratory symptoms effectively.

Precautions & Warnings

  • Trelegy Ellipta 62.5 ug/1 should be used as directed by a healthcare professional. It is important to follow the prescribed dosage and administration instructions to ensure safety and effectiveness. Patients with certain medical conditions, such as severe asthma or heart problems, should discuss their use of this inhaler with their doctor before starting treatment.

Avoid Interactions

  • Trelegy Ellipta 62.5 ug/1 may interact with other medications, including beta-blockers, diuretics, and certain antibiotics. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Additionally, the use of alcohol or other respiratory depressants should be discussed with a healthcare professional.

FAQ's

Trelegy Ellipta 62.5 ug/1 is used for the maintenance treatment of chronic obstructive pulmonary disease (COPD) and asthma.

Trelegy Ellipta 62.5 ug/1 is administered via inhalation, typically once daily. Follow the instructions provided by your healthcare professional.

Common side effects may include throat irritation, headache, and a dry mouth. These effects are usually mild and temporary.

Trelegy Ellipta 62.5 ug/1 may interact with other medications, so it is important to discuss all your current medications with your healthcare provider.

Trelegy Ellipta 62.5 ug/1 may not be suitable for everyone, especially those with severe asthma or heart problems. Consult your healthcare professional for personalized advice.

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. It is not exhaustive and may not cover all medical conditions, treatments, or precautions. Always consult a qualified healthcare professional regarding any medical concerns. Do not ignore or delay seeking medical advice based on information provided here.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer / TM Owner" section in compliance with statutory requirements.

By continuing to access or use this website, you acknowledge and agree to the terms set forth herein. If you do not consent to these terms, you are advised to discontinue browsing immediately. Should you identify any inaccuracy, infringement, or other concern, you are encouraged to promptly report the matter for review and appropriate action. If you wish to request the removal of a product or any part of its content, please contact us at legal@gnhindia.com.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

03

Confirm & Make Payment

Discuss any queries you may have, approve the estimate, and complete your payment.

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence in pharmaceutical distribution.

GSDP Compliant from SGS

URS ISO 9001 Certification

Licensed by FDA Maharashtra

IEC License issued by DGFT